Allowing today’s children and adolescents to become tomorrow’s adult role models Our Paediatric and Perinatal Research Hub allows us to promote research in the fields of paediatrics and adolescence. In doing so, it highlights the centre’s vast expertise while uniting efforts and capabilities in order to undertake global change initiatives that allow us to achieve the objectives agreed upon by the entire community of professionals who participate in paediatric and adolescence research at the Vall d'Hebron Campus. Discover the hub's groups See more The Hub in figures 32 32 Of all the VHIR’s groups participate in paediatric research 8 8 Research groups focusing exclusively on paediatrics 22 22 PIs focusing exclusively on paediatrics 432 432 Publications 3,354 3K Impact factor (total) 7 7 Impact Factor (average) 68 68 % publications Q1 179 179 Ongoing paediatric clinical trials 70 70 Ongoing competitive paediatric projects Consult the evolution in graphics From research to healthcare Mission: To promote, develop and transfer the paediatric research work undertaken at Vall d'Hebron University Hospital. Through excellence in our research work, we improve the health and quality of life of children and adolescents. Vision: We want Vall d'Hebron’s paediatric research work to become a global benchmark which has a positive impact on the health and quality of life of paediatric patients and society in general. Strategic lines Pediatric clinical trials As leaders in research, Vall d'Hebron Research Institute are involved in many clinical trials to children and adolescents. In this list you will be able to consult the pediatric clinical trials in which they are working, as well as the phase in which it is and if there has active recruitment. See clinical trials Organization chart Documentation of strategic lines Organization and structure Clinical Trials and Advanced Therapies Training, mentoring and research promotion Innovation and knowledge transfer Collaboration, reference networks and fundraising Active patients participation Today Related news El Legado de Pol raises €20,761 for research into a rare leukemia in Vall d'Hebron The charitable initiative created in honor of Pol is supporting a research project aimed at identifying therapeutic targets to treat a rare type of leukemia. Vall d'Hebron participates in demonstrating the first treatment against childhood migraine The treatment with fremanezumab becomes the first approved therapy to demonstrate efficacy in children and adolescents, a key stage of life as it is one of the most disabling and concentrates the peak incidence of the disease. Vall d’Hebron takes part in the second General Assembly of the European project RealiseD The initiative aims to transform and improve how clinical trials are conducted in the field of rare diseases. See more Do you want to collaborate with us? With your help we can increase knowledge of the different parologies that affect children and adolescents, improve diagnosis and discover new therapeutic approaches that have an impact on the quality of life of patients and their families. More information
